Mortality of patients with implanted cardioverter/defibrillators in relation to episodes of atrial fibrillation

Europace

Volumn 6, Issue 2, 2004, Pages 151-158

  Deneke, Thomas ^a   Lawo, Thomas ^a   Gerritse, Bart ^b   Lemke, Bernd ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b MEDTRONIC BAKKEN RESEARCH CENTER   (Netherlands)

Author keywords

Implantable defibrillators; Mortality; Recurrent atrial fibrillation

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; ANAMNESIS; ARTICLE; CONTROLLED STUDY; DEFIBRILLATOR; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; SURVIVAL TIME; CASE CONTROL STUDY; CLINICAL TRIAL; EVALUATION; MIDDLE AGED; MULTICENTER STUDY; PROPORTIONAL HAZARDS MODEL; SURVIVAL; TACHYCARDIA; TIME;

ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CASE-CONTROL STUDIES; DEFIBRILLATORS, IMPLANTABLE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TACHYCARDIA; TIME FACTORS;

EID: 3042763020     PISSN: 10995129     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eupc.2003.11.008     Document Type: Article

References (23)

1. Stevenson W.G. Stevenson L.W. Atrial fibrillation in heart failure N Engl J Med 341 1999 910-911
2. Dries D.L. Exner D.V. Gersh B.J. et al. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials J Am Coll Cardiol 32 1998 695-703
3. Middlekauff H.R. Stevenson W.G. Stevenson L.W. Prognostic significance of atrial fibrillation in advanced heart failure: a study of 390 patients Circulation 84 1991 40-48
4. The AFFIRM Investigators Atrial fibrillation following investigation of rhythm management (AFFIRM) study design Am J Cardiol 79 1997 1198-1202
5. Nattel S. Newer developments in the management of atrial fibrillation Am Heart J 130 1995 1094-1106
6. Sopher S.M. Camm A.J. Atrial fibrillation: maintenance of sinus rhythm versus rate control Am J Cardiol 77 1996 24A-37A
7. Stafford R.S. Singer D.E. Recent national patterns of warfarin use in atrial fibrillation Circulation 97 1998 1231-1233
8. Carson P.E. Johnson G.R. Dunkman W.B. et al. The influence of atrial fibrillation on prognosis in mild to moderate heart failure. The V-HeFT Studies Circulation Suppl VI 1993 VI 102-VI 110
9. Grogan M. Smith H.C. Gersh B.J. Wood D.W. Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy Am J Cardiol 69 1992 1570-1575
10. Shinbane J.S. Wood M.A. Jensen D.N. et al. Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies J Am Coll Cardiol 29 1997 709-715
11. Clark D.M. Plumb V.J. Epstein A.E. Kay G.N. Hemodynamic effects of irregular sequence of ventricular cycle lengths during atrial fibrillation J Am Coll Cardiol 30 1997 1039-1045
12. Skinner N.S. Mitchell J.H. Wallace A.G. Sarnoff S.J. Hemodynamic consequences of atrial fibrillation at constant ventricular rates Am J Med 36 1964 342-350
13. Stevenson W.G. Stevenson L.W. Middlekauff H.R. et al. Improving survival for patients with atrial fibrillation and advanced heart failure J Am Coll Cardiol 28 1996 1458-1463
14. S-Plus 2000 guide to statistics vol. 2 1999 238-240 Mathsoft Inc
15. Allison P.D. Survival analysis using the SAS system - a practical guide 1995 SAS Institute Inc
16. Multicenter automatic defibrillator implantation trial (MADIT): design and clinical protocol. MADIT Executive Committee Pacing Clin Electrophysiol 14 1991 920-927
17. Fuster V. Rydén L.E. Asinger R.W. et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences Circulation 104 2001 2118-2150
18. Dries D.L. Rosenber Y.D. Waclawiw M.A. Domanski M.J. Ejection fraction and the risk of thromboembolic events in patients with systolic dysfunction and sinus rhythm: evidence for gender differences in the SOLVED trial J Am Coll Cardiol 29 1997 1074-1080
19. Benjamin E.J. Wolf P.A. D'Agostino R.B. et al. Impact of atrial fibrillation on the risk of death. The Framingham Heart Study Circulation 98 1998 946-952
20. Godtfredsen J. Atrial fibrillation: course and prognosis: a follow-up study of 1212 cases, In: Kulbertus H.E. Olsson S.B. Schlepper M. (Eds.). Atrial fibrillation 1982 134-145 AB Hassle Molndal, Sweden
21. Krahn A.D. Manfreda J. Tate R.B. et al. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba follow-up study Am J Med 98 1995 476-484
22. Flegel K.M. Shipley M.J. Rose G. Risk of stroke in non-rheumatic atrial fibrillation Lancet 1 1987 526-529
23. Deedwania P.C. Singh B.M. Ellenbogen K. et al. for the Department of Veterans Affairs CHF-STAT Investigators Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation. Observations from the Veterans Affairs Congestive Heart Failure Survival Trial of Antiarrhythmic Therapy (VHF-STAT) Circulation 98 1998 2574-2579